Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Findings show it’s possible to identify these patients in advance, helping them to focus on other effective clinical trials of treatments.
Cancer Health spoke with the Foundation for Women’s Cancer about gynecologic cancer education, prevention and eradication.
The study isn’t conclusive, but if there is an increased risk, it’s likely to be very small.
When you ask patients what’s most important to them, they want to know what’s going to help them live longer overall.
A study in mice suggests that therapies approved for breast cancer may also combat other types, including colorectal and stomach cancer.
The three studies tested Zejula, Lynparza and veliparib in women with newly diagnosed advanced ovarian cancer.
The indication is for people with advanced ovarian, fallopian tube, or primary peritoneal cancer treated with prior chemotherapy regimens.
This type of ovarian cancer is the deadliest form of the disease largely because it doesn’t respond to chemotherapy.
HBOC Week recognizes anyone affected by hereditary breast, ovarian and related cancers.
September is Gynecologic Cancer Awareness Month.
September is Ovarian Cancer Awareness Month
Having cancer taught me to try to find as much joy where you can get it.
The Affordable Care Act erases racial disparities in care for advanced cancers.
The test was able to identify many cancers, and their location, at early stages.
Gaby Kressly, now in her early 80s, was diagnosed with ovarian cancer in 2016.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.